Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
I. Viard, P. Wehrli, R. Bullani, P. Schneider, N. Holler, and D. Salomon Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin Science 282 1998 490 493
Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis
P. Paquet, A. Nikkels, J.E. Arrese, A. Vanderkelen, and G.E. Pierard Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis Arch Dermatol 130 1994 605 608
Evaluation of the potential role of cytokines in toxic epidermal necrolysis
A. Nassif, H. Moslehi, S. Le Gouvello, M. Bagot, L. Lyonnet, and L. Michel Evaluation of the potential role of cytokines in toxic epidermal necrolysis J Invest Dermatol 123 2004 850 855
Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis
M. Fischer, E. Fiedler, W.C. Marsch, and J. Wohlrab Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis Br J Dermatol 146 2002 707 709
Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: A retrospective, multicenter study
C. Prins, C. Vittorio, R.S. Padilla, T. Hunziker, P. Itin, and J. Forster Effect of high-dose intravenous immunoglobulin therapy in Stevens-Johnson syndrome: a retrospective, multicenter study Dermatology 207 2003 96 99
Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease
J.M. Van den Brande, H. Braat, G.R. van den Brink, H.H. Versteeg, C.A. Bauer, and I. Hoedemaeker Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease Gastroenterology 124 2003 1774 1785